Table 1 Patient characteristics
From: Chronic non-transmural infarction has a delayed recovery of function following revascularization
Mean age, y | 69 (range 53-84) |
Male, n (%) | 17 (94) |
Caucasian race, n (%) | 18 (100) |
1-vessel disease, n (%) | 3 (17) |
2-vessel disease, n (%) | 8 (44) |
3-vessel disease, n (%) | 7 (39) |
Diabetes, n (%) | 7 (39) |
Baseline LVEF*, % | 47 ± 11 |
Baseline medication with... | |
Beta-blocker, n (%) | 15 (83) |
Angiotensin converting enzyme inhibitor, n (%) | 10 (56) |
Diuretic, n (%) | 5 (28) |
Baseline MR, median days from revascularization | -4 (IQR -7 to -2) |
Baseline rest SPECT, median days from revascularization | -4 (IQR -7 to -4) |
Baseline stress SPECT, median days from revascularization | -1 (IQR -6 to -1) |
One month MR, median days from revascularization | 35 (IQR 29 to 42) |
One month SPECT, median days from revascularization | 31 (IQR 28 to 38) |
One month SPECT, median days from revascularization | 33 (IQR 29 to 41) |
Six month MR, median days from revascularization | 196 (IQR 187 to 207) |
Six month SPECT, median days from revascularization | 196 (IQR 187 to 207) |
Six month SPECT, median days from revascularization | 197 (IQR 188 to 208) |